Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

Highly pathogenic avian influenza represents a severe public health threat. Over the last decade, the demand for highly efficacious vaccines against avian influenza viruses has grown, especially after the 2013 H7N9 outbreak in China that resulted in over 600 human cases with over 200 deaths. Current...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenlan Alex, Zhang, Jinjin, Hall, Katie M., Martin, Carol B., Kisselev, Serguei, Dasen, Emily J., Vahanian, Nicholas N., Link, Charles J., Martin, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546595/
https://www.ncbi.nlm.nih.gov/pubmed/28787006
http://dx.doi.org/10.1371/journal.pone.0182683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546595/
https://www.ncbi.nlm.nih.gov/pubmed/28787006
http://dx.doi.org/10.1371/journal.pone.0182683

Ejemplares similares